
<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=0">
        <meta name="ad.size" content="width=728,height=90">
        <title>Apokyn 728x90</title>
        <link rel="stylesheet" href="css/main.css"/>
        <link rel="preconnect" href="https://fonts.googleapis.com">
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link href="https://fonts.googleapis.com/css2?family=Fira+Sans:wght@500&family=Quicksand:wght@700&family=Roboto+Condensed:wght@400;700&display=swap" rel="stylesheet"> 
        <script type="text/javascript">
            function clicktagExit(url){
                window.open(url, '_blank');
            }
             var clickTag1 = "https://www.apokyn.com";
             var clickTag2 = "https://www.apokyn.com/be-on-with-apokyn";
             var clickTag3 = "https://www.apokyn.com/sites/g/files/othskp476/files/2021-02/apokyn_PPI.pdf#page=1";
             var clickTag4 = "https://www.apokyn.com/sites/g/files/othskp476/files/2021-02/apokyn_PPI.pdf#page=28";
             var clickTag5 = "https://www.fda.gov/medwatch";
             var clickTag6 = "https://www.apokyn.com/sites/all/themes/apokyn/content/resources/apokyn_pi.pdf";
        </script>
    </head>
    <body>
        <div id="mainContainer">
            <div id="container">
                <!--Animation Container-->
                <div class="wrapper">
    
                    <!-- Frame 2 -->
                    <div id="frame2" class="adSize trans">
                        <div id="bg_f2" class="adSize trans"></div>
                        <div id="f2_copy" class="fadeUp quickBold">
                            So you<br>
                            can do<br>
                            more
                        </div>
    
                        <div id="f2_footer" class="quickBold">
                            Actor portrayal
                        </div>
                    </div>
    
                    <!-- Frame 3 -->
                    <div id="frame3" class="adSize">
                        <div id="f3_copy" class="fadeUp quickBold">
                            APOKYN<sup>&reg;</sup> can quickly<br>
                            reverse <span style="color: #007298;">OFF</span> episodes
                        </div>
                    </div>
    
                    <!-- Frame 4 -->
                    <div id="frame4" class="adSize">
                        <div id="f4_copy" class="fadeUp quickBold">
                            Why settle for<br>
                            <span style="color: #007298;">OFF</span> mornings?
                        </div>
                    </div>
                    
                    <!-- Frame 5 -->
                    <div id="frame5" class="adSize">
                        <div id="f5_copy1" class="fadeUp quickBold">
                            APOKYN can help<br>
                            make your mornings
                        </div>
    
                        <div id="f5_copy2" class="fadeUp quickBold">
                            Ask your doctor if itâ€™s right for you
                        </div>
                    </div>
    
                </div>
    
                <div id="logo" class="fadeUp wrapper"></div>
    
                <a href="javascript:window.open(window.clickTag1);void(0);">
                    <div id="hotspot1" class="hotspot1"></div>
                </a>

                <div id="cta" class="cta fadeUp">
                    <p id="ctaText" class="quickBold">LEARN MORE</p>
                </div>
    
                <div id="IRI_mainContainer" class="transition">
                    <div id="isiContainer">
                        <div id="isiContent" class="robotoCondensedReg">
                        
                            <p class="headertxt" style="padding-top: 0px;">
                                Who should not take APOKYN?
                            </p>
        
                            <p class="bold_text" style="padding-top: 5px;">
                                Do not take APOKYN if you are:
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                taking certain medicines to treat nausea called 5HT<sub class="isi_sub">3</sub> antagonists
                                including Anzemet<sup class="isi_sup">&reg;</sup> (dolasetron), Kytril<sup class="isi_sup">&reg;</sup> (granisetron), Zofran<sup class="isi_sup">&reg;</sup>
                                (ondansetron), Lotronex<sup class="isi_sup">&reg;</sup> (alosetron), and Aloxi<sup class="isi_sup">&reg;</sup> (palonosetron).
                                People taking Zofran<sup class="isi_sup">&reg;</sup> (ondansetron) together with apomorphine,
                                the active ingredient in APOKYN, have had very low blood pressure
                                and lost consciousness or "blacked out."                        
                            </p>
        
                            <p class="mainbullet" style="margin-top:4px; padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                allergic to APOKYN or its ingredients and experience hives, itching,
                                rash, or swelling (e.g., eyes, tongue, etc.). APOKYN also contains
                                a sulfite called sodium metabisulfite. Sulfites can cause severe, life-
                                threatening allergic reactions in some people, especially people
                                with asthma.
                            </p>
        
                            <p class="headertxt" style="padding-top: 7px;">
                                What should I tell my healthcare provider before taking APOKYN?
                            </p>
                            
                            <p class="bold_text" style="padding-top: 3px;">
                                Before you start using APOKYN, tell your healthcare provider
                                if you:
                            </p>
        
                            <p class="mainbullet" style="padding-top: 3px;">
                                <span class="bullet">&#8226;</span>
                                have difficulty staying awake during the daytime
                                <span class="inline-bullet">&#8226;</span>
                                have dizziness, fainting spells or low blood pressure
                                <span class="inline-bullet">&#8226;</span>
                                have asthma
                                <span class="inline-bullet">&#8226;</span>
                                are allergic to any medicines containing sulfites
                                <span class="inline-bullet">&#8226;</span>
                                have liver, kidney or heart problems
                                <span class="inline-bullet">&#8226;</span>
                                have had a stroke or other brain problems
                                <span class="inline-bullet">&#8226;</span>
                                have a mental problem called a major psychotic disorder
                                <span class="inline-bullet">&#8226;</span>
                                drink alcohol
                                <span class="inline-bullet">&#8226;</span>
                                are pregnant or plan to become pregnant, or if you are
                                breastfeeding or plan to breastfeed. It is not known if APOKYN will
                                harm your unborn baby or if APOKYN passes into your breast milk.
                            </p>
        
                            <p class="reg_text" style="padding-top: 3px;">
                                <b>Tell your healthcare provider about all the medicines you take,</b>
                                including prescription and non-prescription medicines, vitamins, and
                                herbal supplements. Using APOKYN with certain other medicines
                                may affect each other and can cause serious side effects.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet"> &#8226;</span>
                                If you take nitroglycerin under your tongue while using APOKYN,
                                your blood pressure may decrease and cause dizziness. After
                                taking nitroglycerin, lie down for at least 45 minutes.
                            </p>
        
                            <p class="headertxt" style="padding-top: 4px;">
                                What should I avoid while using APOKYN?
                            </p>
        
                            <p class="mainbullet" style="padding-top: 5px;">
                                <span class="bullet">&#8226;</span>
                                <b>Do not</b> drink alcohol while using APOKYN. It can increase your
                                chance of developing serious side effects.
                            </p>

                            <p class="mainbullet" style="padding-top: 5px;">
                                <span class="bullet">&#8226;</span>
                                <b>Do not</b>
                                take medicines that make you sleepy while you are using
                                APOKYN.
                            </p>

                            <p class="mainbullet" style="padding-top: 5px;">
                                <span class="bullet">&#8226;</span>
                                <b>Do not</b>
                                drive, operate machinery, or do other dangerous activities
                                until you know how APOKYN affects you.
                            </p>
                                
                            <p class="mainbullet" style="padding-top: 5px;">
                                <span class="bullet">&#8226;</span>
                                <b>Do not</b>
                                change your body position too fast. Get up slowly from
                                sitting or lying. APOKYN can lower your blood pressure and cause
                                dizziness or fainting.
                            </p>
        
                            <p class="headertxt" style="padding-top: 4px;">
                                What are the possible side effects of APOKYN?
                            </p>
                            
                            <p class="bold_text" style="padding-top: 3px;">
                                Tell your healthcare provider if you experience the following
                                serious side effects:
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>blood clots.</b>
                                Injecting APOKYN into a vein (intravenous) can cause
                                blood clots. Do not inject APOKYN in your vein.
                            </p>
                                
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>nausea and vomiting.</b>
                                Severe nausea and vomiting can happen
                                with APOKYN. Your healthcare provider may prescribe medicine
                                called an antiemetic, such as trimethobenzamide (Tigan<sup class="isi_sup">&reg;</sup> ), to help
                                prevent it. If Tigan is prescribed, talk to your healthcare provider
                                about how long you should remain on this medicine.
                            </p>
                                
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>sleepiness or falling asleep during the day.</b>
                                Some people
                                treated with APOKYN may get sleepy during the day or fall asleep
                                without warning while doing everyday activities such as talking,
                                eating, or driving a car.
                            </p>
                                
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>dizziness.</b>
                                APOKYN can lower your blood pressure and cause
                                dizziness. Dizziness can happen when APOKYN treatment is
                                started or when the dose is increased. Do not get up too fast from
                                sitting or lying down, especially if you have been sitting or lying
                                down for a long period of time.
                            </p>

                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>falls.</b>
                                The changes that can happen with PD, and the effects of
                                some PD medicines, can increase the risk of falling. APOKYN may
                                also increase your risk of falling.
                            </p>
                                
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>hallucinations or psychotic-like behavior.</b>
                                APOKYN can cause
                                or worsen psychotic-like behavior including hallucinations (seeing
                                or hearing things that are not real), confusion, excessive
                                suspicion, aggressive behavior, agitation, delusional beliefs
                                (believing things that are not real), and disorganized thinking.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>sudden uncontrolled movements (dyskinesias).</b>
                                Some people
                                with PD may get sudden, uncontrolled movements after treatment
                                with some PD medicines. APOKYN can cause or make dyskinesias
                                worse.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>intense urges.</b>
                                Some people with PD have reported new
                                or increased gambling urges, increased sexual urges, and other
                                intense urges, while taking PD medicines, including APOKYN.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>heart problems.</b>
                                If you have shortness of breath, fast heartbeat,
                                or chest pain while taking APOKYN, call your healthcare provider
                                or get emergency help right away.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>serious heart rhythm changes (QT prolongation).</b>
                                Tell your
                                healthcare provider right away if you have a change in
                                your heartbeat (a fast or irregular heartbeat), or if you faint.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>injection site problems.</b>
                                Bruising, swelling, and itching can
                                happen at the injection site.
                            </p>
        
                            <p class="mainbullet" style="padding-top: 4px;">
                                <span class="bullet">&#8226;</span>
                                <b>prolonged painful erections (priaprism).</b>
                                APOKYN may cause
                                prolonged, painful erections in some people. If you have an
                                erection that lasts more than 4 hours you should call your
                                healthcare provider or go to the nearest hospital emergency room
                                right away.
                            </p>
        
                            <p class="bold_text" style="padding-top: 12px;">
                                Other common side effects of APOKYN include:
                            </p>
        
                            <p class="mainbullet" style="padding-top: 3px; margin-top: -3px;">
                                <span class="bullet" style="padding-left: 0px;">&#8226;</span>
                                yawning
                                <span class="inline-bullet"">&#8226;</span>
                                runny nose
                                <span class="inline-bullet"">&#8226;</span>
                                confusion
                                <span class="inline-bullet"">&#8226;</span>
                                swelling of ankles/legs
                            </p>
        
                            <p class="reg_text" style="padding-top: 10px;">
                                You are encouraged to report negative side effects of prescription
                                drugs to the FDA. Visit 
                                <a href="javascript:window.open(window.clickTag5);void(0);" style="color: #636466;">
                                    <u>www.fda.gov/medwatch</u>
                                </a>
                                or call 1-800-FDA-1088.
                            </p>
        
                            <p class="headertxt" style="padding-top: 10px;">
                                What is APOKYN?
                            </p>
        
                            <p class="reg_text" style="padding-top: 4px;">
                                APOKYN is a prescription medicine used to treat acute, intermittent
                                "off" episodes (end-of-dose wearing "off" or unpredictable "on-off"
                                episodes) in people with advanced Parkinsonâ€™s disease (PD).
                            </p>

                            <p class="reg_text" style="padding-top: 4px;">
                                It is not known if APOKYN is safe and effective in children.
                            </p>
        
                            <p class="headertxt" style="padding-top: 4px;">
                                Patients and care partners must receive complete instructions on
                                the proper use of APOKYN. Please see full 
                                <a href="javascript:window.open(window.clickTag6);void(0);" style="color: #76BC21;">
                                    <u>Prescribing Information</u>
                                </a>
                                and
                                <u>
                                    <a href="javascript:window.open(window.clickTag3);void(0);" style="color: #76BC21;">Pen Instructions for Use</a>/<a href="javascript:window.open(window.clickTag4);void(0);" style="color: #76BC21;">Patient Information</a></u>.
                            </p>
        
                                            
                            <!-- <a href="javascript:clicktagExit(clickTag5)"> -->
                                <div id="supernusLogo"></div>
                            <!-- </a> -->
        
                            <p class="bottom_isi_copy">
                                MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc., is the exclusive
                                licensee and distributor of APOKYN in the United States and Its territories. Â© 2022. APOKYN is
                                a registered trademark of BRITUSWIP. APO.2022-0024 03/22
                            </p>
                        </div>
                    </div>
    
                    <div id="isiHeader">
                        <div id="ihText" class="robotoCondensedBold" style="user-select:none;cursor:default;">
                            IMPORTANT SAFETY INFORMATION & INDICATION
                        </div>
    
                        <!-- TO EXPAND BTN -->
                            <div id="isiBtnP" onclick="expandIRI();"></div>
                            <!-- TO COLLAPSE BTN -->
                            <div id="isiBtnM" onclick="collapseIRI();"></div>
                    </div>
    
                    <div id="scrollBg">
                        <div id="scrollBar"></div>
                    </div>
    
                </div>
    
            </div>
    
            <!-- Frame 1 -->
            <div id="frame1" class="adSize trans">
                <div id="bg_f1" class="wrapper"></div>
                <div id="f1_copy" class="quickBold">
                    Less waiting<br>
                    for your meds<br>
                    to kick in
                </div>
    
                <div id="f1_footer" class="quickBold">
                    Actor<br>
                    portrayal
                </div>
    
                <a href="javascript:window.open(window.clickTag1);void(0);">
                    <div id="hotspot2" class="hotspot1"></div>
                </a>
    
            </div>
    
            <div id="isiHeaderBottom">
                <div id="ihTextBottom" class="firaMed">
                    Please see 
                    <a href="javascript:window.open(window.clickTag3);void(0);" style="color: #ffffff;">
                        <u>Pen Instructions for Use</u>
                    </a> 
                    and 
                    <a href="javascript:window.open(window.clickTag4);void(0);" style="color: #ffffff;">
                        <u>Patient Information</u>.
                    </a>
                    <div id="ihFooterArrow"></div>
                </div>
            </div>
        </div>
        
        <!--<div id="guide" class="guide" style="background: url('guide/guide1.png'); width: 728px; height: 90px; position:absolute; background-size: contain; top: 0px; left:0px; opacity:.5;"></div>--> 
        <!-- <div id="guide" class="guide" style="background: url('guide/guideISI.png'); width: 728px; height: 713px; position:absolute; background-size: contain; opacity:.5; top: -1px; left:-1px; background-repeat: no-repeat; display: none;"></div> -->

        
        <script src="js/wFunction-2.5.0.js"></script>
        <script>
        /* Preload Images */
    var images;
    var loadedImage = 0;

    var ua = window.navigator.userAgent;
    var msie = ua.indexOf("MSIE ");

    var expandOn11 = true;

    var iShine = 0,
        frame1End=false,
        loaded=false,
        shineIntervel;

    // image source/file location
    function preloadImages() {
        images = new Array(
            "img/bg_f1.png",
            "img/bg_f2.jpg",
            "img/logo.png",
            "img/cta.png",
            "img/footerArrow.png",
            "img/isiBtnP.png",
            "img/isiBtnM.png",
            "img/supernusLogo.png"

        );

        for(var i=0; i< images.length; i++) {
            imageObj = new Image();
            imageObj.src=images[i];
            imageObj.addEventListener("load",iLoad,false)
        }
    }

    // Load all your assets/images
    function iLoad(){
        loadedImage++;
        if(images.length == loadedImage) {
            w('bg_f1').changeStyle('background-image', 'url("' + images[0] + '")');
            w('bg_f2').changeStyle('background-image', 'url("' + images[1] + '")');
            w('logo').changeStyle('background-image', 'url("' + images[2] + '")');
            w('cta').changeStyle('background-image', 'url("' + images[3] + '")');
            w('ihFooterArrow').changeStyle('background-image', 'url("' + images[4] + '")');
            w('isiBtnP').changeStyle('background-image', 'url("' + images[5] + '")');
            w('isiBtnM').changeStyle('background-image', 'url("' + images[6] + '")');
            w('supernusLogo').changeStyle('background-image', 'url("' + images[7] + '")');
            

            if(UserBrowser.isMac()){
                if(UserBrowser.isFireFox()){
                }
                if(UserBrowser.isChrome()){
                }
            }else{
                if(UserBrowser.isFireFox()){
                }
            }
            if(UserBrowser.isSafari()){
            }
            if(UserBrowser.isMsie()){
            }

             collapseIRI();
             events();
    
            setTimeout(makeVisible, 500);
        }
    }


    function makeVisible() {
        loaded=true;
        w('IRI_mainContainer').changeStyle('visibility','visible');
        w('mainContainer').changeStyle('visibility','visible');
        w('container').changeStyle('visibility','visible');
        w('frame1').changeStyle('visibility','visible');
        w('isiHeaderBottom').changeStyle('visibility','visible');
        frame1();
    }

    function frame1() {
        setTimeout(function () {
            w('frame1').changeStyle('opacity','0');
            setTimeout(function () {
                frame1End = true;
                frame2();
            }, 1000);  
        }, 2000);  
    }

    function frame2(){
        w('cta').changeStyle('opacity;transform','1;translateY(0px)');
        w('logo').changeStyle('opacity;transform','1;translateY(0px)');
        setTimeout(function () {
            w('frame1').changeStyle('visibility','hidden');
            w('f2_copy').changeStyle('opacity;transform','1;translateY(0px)');
            setTimeout(function () {
                w('frame2').changeStyle('opacity','0');
                frame3();
            }, 2000);  
        }, 500);  
    }

    function frame3(){
        setTimeout(function () {
            w('f3_copy').changeStyle('opacity;transform','1;translateY(0px)');
            setTimeout(function () {
                w('f3_copy').changeStyle('opacity','0');
                frame4();
            }, 2000);  
        }, 500);  
    }

    function frame4(){
        setTimeout(function () {
            w('f4_copy').changeStyle('opacity;transform','1;translateY(0px)');
            setTimeout(function () {
                w('f4_copy').changeStyle('opacity','0');
                frame5();
            }, 2000);  
        }, 500);  
    }

    function frame5(){
        setTimeout(function () {
            w('f5_copy1').changeStyle('opacity;transform','1;translateY(0px)');
            w('f5_copy2').changeStyle('opacity;transform','1;translateY(0px)');
        }, 500);  
    }

    var iriIsExpanded = false;
    function iriExpandClick(){
        w('ihPlus').changeStyle('cursor','pointer');
        ihPlus.addEventListener("click",function(){
            if(iriIsExpanded){
                collapseIRI();
                iriIsExpanded = false;
            }else{
                expandIRI();
                iriIsExpanded = true;
            }
        });
    }

    function events() {
        cta.addEventListener('click', function() {
            clicktagExit(clickTag2);
        }, false);
    }


    //Properties,Classes For Collapse IRI
    function collapseIRI(){
        if(frame1End == false && loaded == true) {
            w('frame1').changeStyle('visibility','visible');
        }
        w('isiBtnM').changeStyle('display','none');
        w('IRI_mainContainer').changeStyle('width','240px');

        w('isiBtnP').changeStyle('display','block');

        w('isiHeader').changeStyle('width','346px');
        w('isiHeader').changeStyle('transform', 'translate(376px, 0px)');
        w('ihText').changeStyle('left', '28px');

        w('supernusLogo').changeStyle('bottom', '38px');

        w('isiContent').changeStyle('transform', 'translate(0px, 0px)');
        w('isiContent').changeStyle('padding', '26px 0px 0px 9px');
        w('isiContent').changeStyle('width', '327px');
        w('scrollBg').changeStyle('height', '53px');
        w('scrollBg').changeStyle('top', '15px');
        w('scrollBg').changeStyle('right', '0px');
        w('scrollBg').changeStyle('transform', 'translate(481px, 0px)');

        w('scrollBar').changeStyle('transform','translate(0px, 0px)');
        w('scrollBar').changeStyle('height','30px');
        w('isiContainer').changeStyle('overflow', 'hidden');

        w('isiContainer').changeStyle('width', '346px');
        w('isiContainer').changeStyle('transform', 'translate(376px, 3px)');

        w('isiHeaderBottom').changeStyle('transform', 'translate(378px, 0px)');
        
       
        var ic = document.getElementById('isiContent');

        wScrollConfig.barId = 'scrollBar';
        wScrollConfig.barX = 0;
        wScrollConfig.barUp = 0;
        wScrollConfig.barDown = 23;

        wScrollConfig.contentId = 'isiContent';
        wScrollConfig.contentX = 0;
        wScrollConfig.contentUp = 0;
        wScrollConfig.contentDown = 1330;
        
        wScrollConfig.contentBarDeduction = 0.2; // For Scroll Bar
        wScrollConfig.contentDeduction = 0.2; // For ISI Content

        wScrollConfig.contentContainerId = 'isiContainer';

        wInitScroll();
    }

    //Properties,Classes For Expand IRI
    function expandIRI(){
        if(frame1End == false) {
            w('frame1').changeStyle('visibility','hidden');
        }
        w('isiBtnM').changeStyle('display','block');
        w('isiBtnP').changeStyle('display','none');

        w('IRI_mainContainer').changeStyle('width','728px');

        w('isiHeader').changeStyle('width','728px');
        w('isiHeader').changeStyle('transform', 'translate(-1px, 0px)');
        w('ihText').changeStyle('left', '30px');

        w('supernusLogo').changeStyle('bottom', '29px');

        w('isiContent').changeStyle('transform', 'translate(0px, 0px)');
        w('isiContent').changeStyle('padding', '29px 0px 0px 12px');
        w('isiContent').changeStyle('width', '703px');

        w('scrollBg').changeStyle('height', '53px');
        w('scrollBg').changeStyle('top', '16px');
        w('scrollBg').changeStyle('right', '0px');
        w('scrollBg').changeStyle('transform', 'translate(-7px, 0px)');

        w('scrollBar').changeStyle('transform','translate(0px, 0px)');
        w('scrollBar').changeStyle('height','30px');
        
        w('isiContainer').changeStyle('overflow', 'hidden');
        w('isiContainer').changeStyle('transform', 'translate(-2px, -1px)');
        w('isiContainer').changeStyle('width', '728px');

        w('isiHeaderBottom').changeStyle('transform', 'translate(378px, 0px)');

        var ic = document.getElementById('isiContent');

        wScrollConfig.barId = 'scrollBar';
        wScrollConfig.barX = 0;
        wScrollConfig.barUp = 0;
        wScrollConfig.barDown = 23;

        wScrollConfig.contentId = 'isiContent';
        wScrollConfig.contentX = 0;
        wScrollConfig.contentUp = 0;
        wScrollConfig.contentDown = 838;
        
        // wScrollConfig.contentBarDeduction = 0.2; // For Scroll Bar
        // wScrollConfig.contentDeduction = 0.2; // For ISI Content

        wScrollConfig.contentContainerId = 'isiContainer';


        wInitScroll();

    }

    setTimeout(preloadImages,1000);
        </script>
    </body>
</html>
